FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4230440064> ?p ?o ?g. }

• W4230440064 endingPage "387" @default.
• W4230440064 startingPage "378" @default.
• W4230440064 abstract "Background:Low-molecular-weight heparin (LMWH) has potential benefit in cats at risk for thromboembolic disease. However, LMWH pharmacokinetics has not been characterized in the cat. Drug effect with LMWH may be evaluated with analysis of factor Xa inhibition (anti-Xa) or thromboelastography (TEG). Hypothesis:Administration of LMWH at previously recommended dosages and schedules to healthy cats will result in inhibition of factor Xa and hypocoagulable TEG. Animals:In vivo research with heparin was performed in 5 purpose-bred cats. Methods:In a prospective study with randomized crossover design, heparin or placebo was administered. Treatments were unfractionated heparin (UFH), 250 IU/kg q6h; dalteparin, 100 IU/kg q12h; enoxaparin, 1 mg/kg q12h; or 0.9% saline, 0.25 mL/kg q6h. Each drug was administered for 5 consecutive days followed by a minimum washout of 14 days. Baseline and post-treatment analyses included anti-Xa, TEG, and prothrombin time/activated partial thromboplastin time. Results:Mean anti-Xa activity 4 hours after enoxaparin (0.48 U/mL) approached the human therapeutic target (0.5–1.0 U/mL); however, mean trough anti-Xa activity was below detection limits. Mean anti-Xa activity 4 hours after dalteparin was lower, and only 1 cat attained therapeutic target at a single time point. Cats receiving UFH attained target anti-Xa activity and changes in TEG at trough and 4 hours. Conclusions: Cats have rapid absorption and elimination kinetics with LMWH therapy. On the basis of pharmacokinetic modeling, cats will require higher dosages and more frequent administration of LMWH to achieve human therapeutic anti-factor Xa activity of 0.5–1 U/mL. Peak anti-Xa activity is predicted at 2 hours after administration of LMWH." @default.
• W4230440064 created "2022-05-11" @default.
• W4230440064 creator A5013294186 @default.
• W4230440064 creator A5017073052 @default.
• W4230440064 creator A5019972788 @default.
• W4230440064 creator A5030791709 @default.
• W4230440064 creator A5032660372 @default.
• W4230440064 creator A5068678810 @default.
• W4230440064 creator A5083787715 @default.
• W4230440064 creator A5083975226 @default.
• W4230440064 creator A5088449257 @default.
• W4230440064 date "2007-05-01" @default.
• W4230440064 modified "2023-10-12" @default.
• W4230440064 title "Anticoagulant Effects of Low-Molecular-Weight Heparins in Healthy Cats" @default.
• W4230440064 cites W1220174878 @default.
• W4230440064 cites W1488133965 @default.
• W4230440064 cites W1511115228 @default.
• W4230440064 cites W1970182419 @default.
• W4230440064 cites W1990608896 @default.
• W4230440064 cites W1990962878 @default.
• W4230440064 cites W2005456687 @default.
• W4230440064 cites W2035114130 @default.
• W4230440064 cites W2039989814 @default.
• W4230440064 cites W2043782383 @default.
• W4230440064 cites W2055682350 @default.
• W4230440064 cites W2065225019 @default.
• W4230440064 cites W2075196907 @default.
• W4230440064 cites W2079151671 @default.
• W4230440064 cites W2080318130 @default.
• W4230440064 cites W2083258650 @default.
• W4230440064 cites W2085438282 @default.
• W4230440064 cites W2108777072 @default.
• W4230440064 cites W2112997753 @default.
• W4230440064 cites W2119731230 @default.
• W4230440064 cites W2137236165 @default.
• W4230440064 cites W2148860097 @default.
• W4230440064 cites W2151241085 @default.
• W4230440064 cites W2473039246 @default.
• W4230440064 cites W284451158 @default.
• W4230440064 cites W4242996085 @default.
• W4230440064 cites W4323966262 @default.
• W4230440064 cites W74963018 @default.
• W4230440064 doi "https://doi.org/10.1111/j.1939-1676.2007.tb02979.x" @default.
• W4230440064 hasPublicationYear "2007" @default.
• W4230440064 type Work @default.
• W4230440064 citedByCount "67" @default.
• W4230440064 countsByYear W42304400642012 @default.
• W4230440064 countsByYear W42304400642013 @default.
• W4230440064 countsByYear W42304400642014 @default.
• W4230440064 countsByYear W42304400642015 @default.
• W4230440064 countsByYear W42304400642016 @default.
• W4230440064 countsByYear W42304400642017 @default.
• W4230440064 countsByYear W42304400642018 @default.
• W4230440064 countsByYear W42304400642019 @default.
• W4230440064 countsByYear W42304400642020 @default.
• W4230440064 countsByYear W42304400642021 @default.
• W4230440064 countsByYear W42304400642022 @default.
• W4230440064 countsByYear W42304400642023 @default.
• W4230440064 crossrefType "journal-article" @default.
• W4230440064 hasAuthorship W4230440064A5013294186 @default.
• W4230440064 hasAuthorship W4230440064A5017073052 @default.
• W4230440064 hasAuthorship W4230440064A5019972788 @default.
• W4230440064 hasAuthorship W4230440064A5030791709 @default.
• W4230440064 hasAuthorship W4230440064A5032660372 @default.
• W4230440064 hasAuthorship W4230440064A5068678810 @default.
• W4230440064 hasAuthorship W4230440064A5083787715 @default.
• W4230440064 hasAuthorship W4230440064A5083975226 @default.
• W4230440064 hasAuthorship W4230440064A5088449257 @default.
• W4230440064 hasBestOaLocation W42304400641 @default.
• W4230440064 hasConcept C112705442 @default.
• W4230440064 hasConcept C126322002 @default.
• W4230440064 hasConcept C142724271 @default.
• W4230440064 hasConcept C162156334 @default.
• W4230440064 hasConcept C204787440 @default.
• W4230440064 hasConcept C27081682 @default.
• W4230440064 hasConcept C2776884760 @default.
• W4230440064 hasConcept C2777557582 @default.
• W4230440064 hasConcept C2777664302 @default.
• W4230440064 hasConcept C2778205648 @default.
• W4230440064 hasConcept C2778261982 @default.
• W4230440064 hasConcept C2778382381 @default.
• W4230440064 hasConcept C2779904517 @default.
• W4230440064 hasConcept C2780434524 @default.
• W4230440064 hasConcept C42219234 @default.
• W4230440064 hasConcept C71924100 @default.
• W4230440064 hasConcept C87813604 @default.
• W4230440064 hasConcept C98274493 @default.
• W4230440064 hasConceptScore W4230440064C112705442 @default.
• W4230440064 hasConceptScore W4230440064C126322002 @default.
• W4230440064 hasConceptScore W4230440064C142724271 @default.
• W4230440064 hasConceptScore W4230440064C162156334 @default.
• W4230440064 hasConceptScore W4230440064C204787440 @default.
• W4230440064 hasConceptScore W4230440064C27081682 @default.
• W4230440064 hasConceptScore W4230440064C2776884760 @default.
• W4230440064 hasConceptScore W4230440064C2777557582 @default.
• W4230440064 hasConceptScore W4230440064C2777664302 @default.
• W4230440064 hasConceptScore W4230440064C2778205648 @default.
• W4230440064 hasConceptScore W4230440064C2778261982 @default.

• next